TY  - JOUR
AU  - Dossus, Laure
AU  - Kouloura, Eirini
AU  - Biessy, Carine
AU  - Viallon, Vivian
AU  - Siskos, Alexandros P
AU  - Dimou, Niki
AU  - Rinaldi, Sabina
AU  - Merritt, Melissa A
AU  - Allen, Naomi
AU  - Fortner, Renee
AU  - Kaaks, Rudolf
AU  - Weiderpass, Elisabete
AU  - Gram, Inger T
AU  - Rothwell, Joseph A
AU  - Lécuyer, Lucie
AU  - Severi, Gianluca
AU  - Schulze, Matthias B
AU  - Nøst, Therese Haugdahl
AU  - Crous-Bou, Marta
AU  - Sanchez-Perez, Maria-Jose
AU  - Amiano, Pilar
AU  - Colorado-Yohar, Sandra M
AU  - Gurrea, Aurelio Barricarte
AU  - Schmidt, Julie A
AU  - Palli, Domenico
AU  - Agnoli, Claudia
AU  - Tumino, Rosario
AU  - Sacerdote, Carlotta
AU  - Mattiello, Amalia
AU  - Vermeulen, Roel
AU  - Heath, Alicia K
AU  - Christakoudi, Sofia
AU  - Tsilidis, Konstantinos K
AU  - Travis, Ruth C
AU  - Gunter, Marc J
AU  - Keun, Hector C
PY  - 2021
DO  - 10.1016/j.ygyno.2021.06.001
UR  - http://hdl.handle.net/10668/17972
T2  - Gynecologic oncology
AB  - Endometrial cancer is strongly associated with obesity and dysregulation of metabolic factors such as estrogen and insulin signaling are causal risk factors for this malignancy. To identify additional novel metabolic pathways associated with...
LA  - en
PB  - Academic Press
KW  - Amino acids
KW  - Endometrial cancer
KW  - Lipids
KW  - Metabolomics
KW  - Obesity
KW  - Aged
KW  - Biomarkers, Tumor
KW  - Body Mass Index
KW  - Carnitine
KW  - Case-Control Studies
KW  - Endometrial Neoplasms
KW  - Female
KW  - Glycine
KW  - Humans
KW  - Metabolomics
KW  - Middle Aged
KW  - Prospective Studies
KW  - Risk Factors
KW  - Serine
KW  - Sphingomyelins
TI  - Prospective analysis of circulating metabolites and endometrial cancer risk.
TY  - research article
VL  - 162
ER  -